RCA Micro vs Signia Pure C&G IX

The RCA Micro is a budget-priced behind-the-ear OTC hearing aid released in 2023, earning a C grade with a SoundScore of 2.7/5 in our lab testing. At $399, it sits in the lowest price tier of the OTC category but ranks last among the 65 OTC hearing aids we've tested. In our standardized testing, the RCA Micro shows a significant performance gap compared to category peers. Speech understanding scores are notably low, with speech in quiet at 1.0/5 (1.79 points below the category average) and speech in noise also at 1.0/5 (0.48 points below average). Music streaming scored 0.0/5, falling 1.92 points below the category average—meaning phone audio streaming is essentially non-functional as a feature. The one bright spot is excellent feedback handling at 5.0/5, which is 0.46 points above the category average, indicating stable performance without whistling during normal use. Own-voice comfort is mixed at 2.1/5, sitting 0.41 points below the category average. This suggests wearers may notice some unnatural quality to their own voice during conversations. At this price point, several alternatives deliver substantially stronger performance. The Elehear Beyond, Apple AirPods Pro 2, and Zepp Clarity Omni all fall within the same price range while scoring significantly higher in our testing. The RCA Micro's rechargeable batteries and simple BTE design offer basic convenience, but consumers seeking meaningful speech clarity improvements should consider higher-performing options in this competitive budget segment.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.